The integration of Real-World Evidence (RWE) into healthcare decision-making is transforming the landscape of pharmaceutical development, pricing, and reimbursement strategies in the United States. To explore these advancements, the EVIDENCE 360: RWE, Pricing & Reimbursement Summit USA is scheduled for June 26-27, 2025, in Philadelphia. Summit Overview This two-day event aims to unite...

The integration of Real-World Evidence (RWE) into healthcare decision-making is transforming how pharmaceutical companies approach Health Economics and Outcomes Research (HEOR), pricing, and reimbursement strategies. To delve into these advancements, the EVIDENCE 360: Real World Evidence, Pricing & Reimbursement Summit Europe is scheduled for 26th-27th May 2025 in Frankfurt, Germany. Summit...

The pharmaceutical industry's pursuit of more effective treatments has led to a significant focus on Highly Potent Active Pharmaceutical Ingredients (HPAPIs). These compounds, known for their efficacy at low doses, are integral to therapies in oncology and other critical areas. However, their potency necessitates stringent measures in development and manufacturing to ensure safety and...